Christopher McCarthy insider trades

Open-market stock purchases and sales by Christopher McCarthy, Chief Financial Officer at Interpace Biosciences, Inc, from SEC Form 4 filings since Jul 31, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • IDXG Interpace Biosciences, Inc: other filings, last Dec 1, 2024

Get free alerts when Christopher McCarthy files a new trade →